Long-term Use of Alogliptin/Pioglitazone Combination Tablets in Patients With Type 2 Diabetes Mellitus
Latest Information Update: 25 Jan 2019
At a glance
- Drugs Alogliptin/pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Takeda
- 15 Apr 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 27 Nov 2013 New trial record